Haug BE - Search Results

1

Influence of chain length on the activity of tripeptidomimetic antagonists for CXC chemokine receptor 4 (CXCR4).

Baumann M, Hussain MM, Henne N, Garrote DM, Karlshøj S, Fossen T, Rosenkilde MM, Våbenø J, Haug BE. Baumann M, et al. Among authors: haug be. Bioorg Med Chem. 2017 Jan 15;25(2):646-657. doi: 10.1016/j.bmc.2016.11.036. Epub 2016 Nov 21. Bioorg Med Chem. 2017. PMID: 27939345

2

The pharmacophore of short cationic antibacterial peptides.

Strøm MB, Haug BE, Skar ML, Stensen W, Stiberg T, Svendsen JS. Strøm MB, et al. Among authors: haug be. J Med Chem. 2003 Apr 24;46(9):1567-70. doi: 10.1021/jm0340039. J Med Chem. 2003. PMID: 12699374

3

The medicinal chemistry of short lactoferricin-based antibacterial peptides.

Haug BE, Strøm MB, Svendsen JS. Haug BE, et al. Curr Med Chem. 2007;14(1):1-18. doi: 10.2174/092986707779313435. Curr Med Chem. 2007. PMID: 17266565 Review.

4

Application of the Suzuki-Miyaura cross-coupling to increase antimicrobial potency generates promising novel antibacterials.

Haug BE, Stensen W, Svendsen JS. Haug BE, et al. Bioorg Med Chem Lett. 2007 Apr 15;17(8):2361-4. doi: 10.1016/j.bmcl.2006.12.049. Epub 2006 Dec 21. Bioorg Med Chem Lett. 2007. PMID: 17350833

5

Synthetic antimicrobial peptidomimetics with therapeutic potential.

Haug BE, Stensen W, Kalaaji M, Rekdal Ø, Svendsen JS. Haug BE, et al. J Med Chem. 2008 Jul 24;51(14):4306-14. doi: 10.1021/jm701600a. Epub 2008 Jun 21. J Med Chem. 2008. PMID: 18570363

6

In silico design, synthesis, and assays of specific substrates for proteinase 3: influence of fluorogenic and charged groups.

Narawane S, Budnjo A, Grauffel C, Haug BE, Reuter N. Narawane S, et al. Among authors: haug be. J Med Chem. 2014 Feb 13;57(3):1111-5. doi: 10.1021/jm401559r. Epub 2014 Jan 21. J Med Chem. 2014. PMID: 24397704

7

Design, synthesis, and biological evaluation of scaffold-based tripeptidomimetic antagonists for CXC chemokine receptor 4 (CXCR4).

Zachariassen ZG, Thiele S, Berg EA, Rasmussen P, Fossen T, Rosenkilde MM, Våbenø J, Haug BE. Zachariassen ZG, et al. Among authors: haug be. Bioorg Med Chem. 2014 Sep 1;22(17):4759-69. doi: 10.1016/j.bmc.2014.07.004. Epub 2014 Jul 14. Bioorg Med Chem. 2014. PMID: 25082513

8

Reversible ketomethylene-based inhibitors of human neutrophil proteinase 3.

Budnjo A, Narawane S, Grauffel C, Schillinger AS, Fossen T, Reuter N, Haug BE. Budnjo A, et al. Among authors: haug be. J Med Chem. 2014 Nov 26;57(22):9396-408. doi: 10.1021/jm500782s. Epub 2014 Nov 12. J Med Chem. 2014. PMID: 25365140

9

Pseudoaeruginosins, nonribosomal peptides in Nodularia spumigena.

Liu L, Budnjo A, Jokela J, Haug BE, Fewer DP, Wahlsten M, Rouhiainen L, Permi P, Fossen T, Sivonen K. Liu L, et al. Among authors: haug be. ACS Chem Biol. 2015 Mar 20;10(3):725-33. doi: 10.1021/cb5004306. Epub 2014 Dec 5. ACS Chem Biol. 2015. PMID: 25419633

10

Progress toward rationally designed small-molecule peptide and peptidomimetic CXCR4 antagonists.

Våbenø J, Haug BE, Rosenkilde MM. Våbenø J, et al. Among authors: haug be. Future Med Chem. 2015;7(10):1261-83. doi: 10.4155/fmc.15.64. Future Med Chem. 2015. PMID: 26144264 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

44 results

Search Page

Filters